Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-3.1%/yr
vs -1.5%/yr prior
5Y CAGR
-3.0%/yr
Consistent
Acceleration
-1.7pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
5 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | 83.85% | -2.8% |
| 2024 | 86.30% | -3.7% |
| 2023 | 89.59% | -2.8% |
| 2022 | 92.21% | -3.4% |
| 2021 | 95.44% | -2.3% |
| 2020 | 97.74% | +7.0% |
| 2019 | 91.31% | -6.6% |
| 2018 | 97.77% | -2.2% |
| 2017 | 99.96% | +100.1% |
| 2016 | -137647.37% | - |